MedPath

Fondation Ophtalmologique Adolphe de Rothschild

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.fo-rothschild.fr

Safety of a Strategy Combining Etanercept Administration with Repeated Contrast Ultrasound in Patients with Alzheimer's Disease

Phase 1
Not yet recruiting
Conditions
Alzheimer Disease
Interventions
Combination Product: etanercept and repeated contrast ultrasound
First Posted Date
2024-09-05
Last Posted Date
2024-10-16
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
5
Registration Number
NCT06585384

Behavioural Study in Chronic Pain : Creativity and Motivation, and Circuits Involved in Functional MRI

Phase 3
Not yet recruiting
Conditions
Chronic Pain
Interventions
Behavioral: art-therapy
Behavioral: relaxation
First Posted Date
2024-07-16
Last Posted Date
2024-07-22
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
48
Registration Number
NCT06502496

Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy

Phase 2
Not yet recruiting
Conditions
Acute Ischemic Stroke
Interventions
Drug: placebo
First Posted Date
2024-05-31
Last Posted Date
2024-07-22
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
304
Registration Number
NCT06437431

Automated Central Retinal Artery Occlusion Diagnosis on Fundus Photographs

Completed
Conditions
CRAO - Central Retinal Artery Occlusion
First Posted Date
2024-04-30
Last Posted Date
2024-04-30
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
693
Registration Number
NCT06390579
Locations
🇫🇷

Hopital Fondation Adolphe de Rothschild, Paris, France

Functional Impairment in Albinism

Recruiting
Conditions
Albinism, Ocular
First Posted Date
2024-04-03
Last Posted Date
2025-02-13
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
50
Registration Number
NCT06345976
Locations
🇫🇷

Hôpital Fondation A. de Rothschild, Paris, France

Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.

Phase 3
Not yet recruiting
Conditions
Ocular Myasthenia Gravis
Interventions
Drug: immediate treatment with corticosteroids
Drug: addition of rituximab if recurrence
First Posted Date
2024-04-02
Last Posted Date
2024-04-02
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
128
Registration Number
NCT06342544

Study of Brain-spinal Cord Neural Connectivity in Spasticity

Not yet recruiting
Conditions
Spasticity, Muscle
First Posted Date
2024-02-28
Last Posted Date
2024-02-28
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
50
Registration Number
NCT06281223

Efficacy and Safety of Anti-angiogenic Therapy with IV Bevacizumab in Patients with Symptomatic Cerebral Arteriovenous Malformations

Phase 2
Not yet recruiting
Conditions
Cerebral AV Malformation
Interventions
Drug: Placebo
First Posted Date
2024-02-20
Last Posted Date
2025-03-25
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
54
Registration Number
NCT06264531

Validation of the French Version of the Hearing Aid Benefit Measurement COSI and IOI-HA Questionnaires

Active, not recruiting
Conditions
Hearing Impairment
First Posted Date
2023-10-31
Last Posted Date
2024-10-16
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
100
Registration Number
NCT06108609
Locations
🇫🇷

Hopital Fondation Adolphe de Rothschild, Paris, France

DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery

Recruiting
Conditions
Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery
First Posted Date
2023-08-28
Last Posted Date
2025-05-22
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Target Recruit Count
80
Registration Number
NCT06013462
Locations
🇫🇷

Fondation Ophtalmologique A de Rothschild, Paris, France

© Copyright 2025. All Rights Reserved by MedPath